Novelix Pharmaceuticals Limited (BOM:536565)

Novelix Pharmaceuticals Statistics

Total Valuation

BOM:536565 has a market cap or net worth of INR 1.05 billion. The enterprise value is 1.06 billion.

Market Cap	1.05B
Enterprise Value	1.06B

Important Dates

The last earnings date was Friday, May 29, 2026.

Earnings Date	May 29, 2026
Ex-Dividend Date	n/a

Share Statistics

BOM:536565 has 19.94 million shares outstanding. The number of shares has increased by 124.99% in one year.

Current Share Class	19.94M
Shares Outstanding	19.94M
Shares Change (YoY)	+124.99%
Shares Change (QoQ)	+64.56%
Owned by Insiders (%)	39.05%
Owned by Institutions (%)	1.25%
Float	4.28M

Valuation Ratios

The trailing PE ratio is 43.53.

PE Ratio	43.53
Forward PE	n/a
PS Ratio	0.79
PB Ratio	2.26
P/TBV Ratio	2.36
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Enterprise Valuation

The stock's EV/EBITDA ratio is 30.34, with an EV/FCF ratio of -4.15.

EV / Earnings	41.60
EV / Sales	0.80
EV / EBITDA	30.34
EV / EBIT	31.24
EV / FCF	-4.15

Financial Position

The company has a current ratio of 2.14, with a Debt / Equity ratio of 0.09.

Current Ratio	2.14
Quick Ratio	1.49
Debt / Equity	0.09
Debt / EBITDA	1.23
Debt / FCF	-0.17
Interest Coverage	n/a

Financial Efficiency

Return on equity (ROE) is 7.99% and return on invested capital (ROIC) is 6.70%.

Return on Equity (ROE)	7.99%
Return on Assets (ROA)	3.56%
Return on Invested Capital (ROIC)	6.70%
Return on Capital Employed (ROCE)	6.70%
Weighted Average Cost of Capital (WACC)	5.89%
Revenue Per Employee	165.42M
Profits Per Employee	3.20M
Employee Count	8
Asset Turnover	2.21
Inventory Turnover	16.59

Taxes

In the past 12 months, BOM:536565 has paid 8.48 million in taxes.

Income Tax	8.48M
Effective Tax Rate	24.90%

Stock Price Statistics

The stock price has increased by +88.51% in the last 52 weeks. The beta is 0.34, so BOM:536565's price volatility has been lower than the market average.

Beta (5Y)	0.34
52-Week Price Change	+88.51%
50-Day Moving Average	54.78
200-Day Moving Average	52.90
Relative Strength Index (RSI)	42.59
Average Volume (20 Days)	4,755

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	n/a

Income Statement

In the last 12 months, BOM:536565 had revenue of INR 1.32 billion and earned 25.57 million in profits. Earnings per share was 1.21.

Revenue	1.32B
Gross Profit	56.24M
Operating Income	34.04M
Pretax Income	34.04M
Net Income	25.57M
EBITDA	35.05M
EBIT	34.04M
Earnings Per Share (EPS)	1.21

Balance Sheet

The company has 29.59 million in cash and 43.22 million in debt, with a net cash position of -13.63 million or -0.68 per share.

Cash & Cash Equivalents	29.59M
Total Debt	43.22M
Net Cash	-13.63M
Net Cash Per Share	-0.68
Equity (Book Value)	464.88M
Book Value Per Share	21.92
Working Capital	472.98M

Cash Flow

In the last 12 months, operating cash flow was -223.89 million and capital expenditures -32.56 million, giving a free cash flow of -256.45 million.

Operating Cash Flow	-223.89M
Capital Expenditures	-32.56M
Depreciation & Amortization	1.01M
Net Borrowing	n/a
Free Cash Flow	-256.45M
FCF Per Share	-12.86

Margins

Gross margin is 4.25%, with operating and profit margins of 2.57% and 1.93%.

Gross Margin	4.25%
Operating Margin	2.57%
Pretax Margin	2.57%
Profit Margin	1.93%
EBITDA Margin	2.65%
EBIT Margin	2.57%
FCF Margin	n/a

Dividends & Yields

BOM:536565 does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-124.99%
Shareholder Yield	-124.99%
Earnings Yield	2.43%
FCF Yield	-24.42%

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value	n/a
Lynch Upside	n/a
Graham Number
Graham Upside

Stock Splits

The last stock split was on October 4, 2010. It was a reverse split with a ratio of 0.1.

Last Split Date	Oct 4, 2010
Split Type	Reverse
Split Ratio	0.1

Scores

Altman Z-Score	n/a
Piotroski F-Score	4